These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35147643)

  • 21. Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance.
    Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Della Morte AM; Pivonello R; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1551-7. PubMed ID: 11297582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
    Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
    Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
    Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
    Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acromegaly associated with type 2 diabetes showing normal IGF-1 levels under poorly controlled glycemia.
    Lim DJ; Kwon HS; Cho JH; Kim SH; Choi YH; Yoon KH; Cha BY; Lee KW; Son HY; Kang SK
    Endocr J; 2007 Aug; 54(4):537-41. PubMed ID: 17575366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acromegaly and pregnancy: report of six new cases].
    Persechini ML; Gennero I; Grunenwald S; Vezzosi D; Bennet A; Caron P
    J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):704-12. PubMed ID: 24035359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance.
    Pivonello R; Galderisi M; Auriemma RS; De Martino MC; Galdiero M; Ciccarelli A; D'Errico A; Kourides I; Burman P; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2007 Feb; 92(2):476-82. PubMed ID: 17105844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell death in acromegalic cardiomyopathy.
    Frustaci A; Chimenti C; Setoguchi M; Guerra S; Corsello S; Crea F; Leri A; Kajstura J; Anversa P; Maseri A
    Circulation; 1999 Mar; 99(11):1426-34. PubMed ID: 10086965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
    Saccà L; Napoli R; Cittadini A
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly.
    Cardinal T; Collet C; Wedemeyer M; Singer PA; Weiss M; Zada G; Carmichael JD
    Front Endocrinol (Lausanne); 2021; 12():743052. PubMed ID: 34867787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acromegaly with normal growth hormone levels: response to Sandostatin-LAR treatment.
    Shimon I; Nass D; Hadani M
    Pituitary; 2000 May; 2(4):289-94. PubMed ID: 11081151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency.
    Skjaerbaek C; Frystyk J; Kaal A; Laursen T; Møller J; Weeke J; Jørgensen JO; Sandahl Christiansen J; Orskov H
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):25-33. PubMed ID: 10651750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement of ventricular arrhythmia by octreotide treatment in acromegalic cardiomyopathy.
    Tachibana H; Yamaguchi H; Abe S; Sato T; Inoue S; Abe S; Yamaki M; Kubota I
    Jpn Heart J; 2003 Nov; 44(6):1027-31. PubMed ID: 14711197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiovascular complications associated with acromegaly. A state-of-the-art].
    Concepción-Zavaleta M; Muñoz-Moreno J; Quispe-Flores M; Rafael-Robles L; Lobato-Jeri C; Ramos-Yataco A; Concepción-Urteaga L; Paz-Ibarra J
    Arch Cardiol Mex; 2022 Oct; 92(4):513-521. PubMed ID: 35389604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impact of growth-factor hormone control on the outcome of acromegalic cardiomyopathy].
    She QF; Bai R; Zhou Q; Yan JT; Wang DW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Apr; 38(4):354-6. PubMed ID: 20654084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular complications in acromegaly.
    Vitale G; Pivonello R; Lombardi G; Colao A
    Minerva Endocrinol; 2004 Sep; 29(3):77-88. PubMed ID: 15282442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Outcome of somatostatin analogue treatment in acromegaly].
    Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
    Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discordant biological parameters of remission in acromegaly do not increase the risk of hypertension or diabetes: a study with the Liege Acromegaly Survey database.
    Amodru V; Petrossians P; Colao A; Delemer B; Maione L; Neggers SJCMM; Decoudier B; Kamenicky P; Castinetti F; Hana V; Pivonello R; Carvalho D; Brue T; Beckers A; Chanson P; Cuny T
    Endocrine; 2020 Oct; 70(1):134-142. PubMed ID: 32562181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.
    Bevan JS; Atkin SL; Atkinson AB; Bouloux PM; Hanna F; Harris PE; James RA; McConnell M; Roberts GA; Scanlon MF; Stewart PM; Teasdale E; Turner HE; Wass JA; Wardlaw JM
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4554-63. PubMed ID: 12364434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-dimensional speckle tracking echocardiography-derived left atrial deformation analysis in acromegaly (Results from the MAGYAR-Path Study).
    Kormányos Á; Domsik P; Kalapos A; Valkusz Z; Lengyel C; Forster T; Nemes A
    Echocardiography; 2018 Jul; 35(7):975-984. PubMed ID: 29569265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.